All Stories

  1. Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand
  2. Antimicrobial stewardship: Prescribing across the primary care health professions
  3. Nurse practitioner and midwife antibiotic prescribing in Australia
  4. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children
  5. Dynamics of Patient-Based Benefit-Risk Assessment of Medicines in Chronic Diseases: A Systematic Review
  6. Trends in Systemic Antifungal Use in Australia, 2005–2016: a Time-Series Analysis
  7. Patient concerns regarding antidepressant drug–drug interactions: a retrospective analysis using data from a medicines call centre
  8. Patient-based benefit-risk assessment of medicines: development, refinement, and validation of a content search strategy to retrieve relevant studies
  9. Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre
  10. Heliox for croup in children
  11. ICU Patients’ Antibiotic Exposure and Triazole-Resistance in Invasive Candidiasis: Parallel Analysis of Aggregated and Individual Data
  12. Trends in Australian dental prescribing of antibiotics: 2005–2016
  13. Anaemia in patients undergoing major bowel surgery – Prevalence and current practice: A public and private institution experience
  14. Withdrawal and Misuse Concerns of Consumers regarding Opioid Analgesic and Anxiolytic, Hypnotic and Sedative Medicines
  15. Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center
  16. Implementing a sustainable medication reconciliation process in Australian hospitals: The World Health Organization High 5s project
  17. Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison
  18. Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?
  19. Poster Presentations
  20. Navigating off‐label and unlicensed medicines use in obstetric and paediatric clinical practice
  21. Network meta-analysis and pharmacoeconomic evaluation of antibiotics for the treatment of patients infected with complicated skin and soft structure infection and hospital-acquired or ventilator-associated penumonia
  22. Longitudinal impact of the Women’s Health Initiative study on hormone therapy use in Australia
  23. Does consumer medicines interest reflect medicines use? An observational study comparing medicines call center queries with medicines use
  24. Editorial: Does size matter? Addressing pack size and antibiotic duration
  25. Medication overuse headache: strategies for prevention and treatment using a multidisciplinary approach
  26. Heliox for croup in children
  27. Letter to the Editor: Maintaining milk supply as the baby grows
  28. Letter to the Editor: Adverse effects of herbs as galactogogues
  29. Gestational diabetes mellitus diagnosis and treatment is not as simple as you think.
  30. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children
  31. Drugs affecting milk supply during lactation
  32. Breastfeeding questions to medicines call centres from the Australian public and health professionals
  33. Australian community pharmacists’ knowledge of popular herbal/nutrient weight-loss complementary medicines
  34. The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition
  35. The use of metformin to treat GDM is increasing; evidence of safety and effectiveness is growing.
  36. Melatonin for non-respiratory sleep disorders in typically developing children
  37. Melatonin for non-respiratory sleep disorders in children with neurodevelopmental disorders
  38. Learnings and challenges to deploy an interprofessional and independent medical education programme to a new audience
  39. Hypersensitivity
  40. What do health consumers want to know about childhood vaccination? An evaluation of data from an Australian medicines call centre
  41. Children's medicine: What do consumers really want to know?
  42. Medication overuse headache in Australia: a call for multidisciplinary efforts at prevention and treatment
  43. Women's questions about medicines in pregnancy - An analysis of calls to an Australian national medicines call centre
  44. Community pharmacist practices, attitudes, recommendations, information and education needs for herbal and nutrient complementary medicines for weight loss
  45. What do consumers want to know about drugs (medication and lifestyle) in their pregnancy journey?
  46. What do health consumers want to know about childhood vaccination?
  47. Consumer concerns about paracetamol: a retrospective analysis of a medicines call centre
  48. Herbal and nutrient complementary medicines for weight loss: community pharmacists' practices, attitudes, recommendations, information and education needs
  49. What do consumers want to know about antibiotics? Analysis of a medicines call centre database
  50. Dopamine Agonists: Time Pattern of Adverse Effects Reporting in Australia
  51. The match between common antibiotics packaging and guidelines for their use in Australia
  52. Consumers’ questions about antipsychotic medication: revealing safety concerns and the silent voices of young men
  53. Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication
  54. Abstracts
  55. Abstracts of the 22nd Cochrane Colloquium
  56. A growing concern
  57. Heliox for croup in children
  58. Monitoring Salivary Melatonin Concentrations in Children With Sleep Disorders Using Liquid Chromatography–Tandem Mass Spectrometry
  59. Sleeping Pills and Quality of Wake Time: The Missing Link
  60. Review: Minimal interventions (e.g., a letter) reduce long-term benzodiazepine use in primary care
  61. Homeopathic remedies for preventing and treating acute respiratory tract infections in children
  62. Melatonin for non-respiratory sleep disorders in visually impaired children
  63. Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis
  64. 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology
  65. Melatonin for non-respiratory sleep disorders in typically developing children
  66. Melatonin for non-respiratory sleep disorders in children with neurodevelopmental disorders
  67. Therapeutic Options in the Management of Sleep Disorders in Visually Impaired Children: A Systematic Review
  68. Treating Diabetes
  69. Drug interactions with complementary medicines
  70. Goodbye TAIS and thanks for all the information!
  71. Melatonin for non-respiratory sleep disorders in visually impaired children
  72. Influenza H1N1 vaccine
  73. Predictors of Safety-Related Enquiries about Psychotropic Medication in Young People and Families Accessing a Medicines Information Service
  74. Headache with medication overuse: treatment strategies and proposals of relapse prevention
  75. The Adverse Medicine Events (AME) Line: Australian Experience with Consumer Pharmacovigilance
  76. Starter packs: a good start to therapy?
  77. Antidepressants in children and adolescents—changes in utilisation after safety warnings
  78. Sleep-Driving, Sleep-Eating and Sleep-Smoking Associated with Zolpidem: Consumers Demonstrating their Valuable Role in Pharmacovigilance
  79. Vaccine components and constituents: responding to consumer concerns
  80. Herbal therapies and substance use
  81. Medicinal Mishap: 'Statins' and muscle symptoms
  82. A sight for sore eyes
  83. Piloting an Objective Structured Clinical Examination to Evaluate the Clinical Competency of Pre-Registration Pharmacists
  84. Cold comfort
  85. Highlights from the 1998 National Medicines Week Phone-In
  86. Wheeze and sneeze
  87. Medication Liaison: an Emerging Philosophy
  88. Conjoint Appointments - a Queensland Perspective
  89. Audit as a Basis for Informed Consent with Cerebral Angiography